Compare Stocks

Abrdn Global Dynamic Dividend Fund is a closed ended equity mutual fund launched and managed by Alpine Woods Capital Investors, LLC. It invests in the public equity markets across the globe. The fund invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across all market capitalizations. The fund employs a fundamental analysis with bottom up and top down stock picking approach, focusing on companies globally with potential for dividend increases and capital appreciation to create its portfolio. It benchmarks the performance of its portfolio against the S&P 500 Index, MSCI AC World Daily TR (Net Div) Index, and MSCI AC World Daily TR ex Japan (Gross Div) Index. Abrdn Global Dynamic Dividend Fund was formed on May 11, 2006 and is domiciled in the United States.

Golden Predator Mining Corp., an exploration stage company, engages in the acquisition and exploration of mineral properties in Canada. The company explores for gold, silver, copper, lead, and zinc properties. Its principal property is the Brewery Creek project covering an area of 180 square kilometers located in northwestern Yukon. The company was formerly known as Northern Tiger Resources Inc. and changed its name to Golden Predator Mining Corp. in April 2014. Golden Predator Mining Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.

Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.